Follicular regulatory T cells (T FR ) have been extensively characterized in mice and participate in germinal center responses by regulating the maturation of B cells and production of (auto)antibodies. We report that circulating T FR are phenotypically distinct from tonsil-derived T FR in humans. They have a lower expression of follicular markers, and display a memory phenotype and lack of high expression of B cell lymphoma 6 and ICOS. However, the suppressive function, expression of regulatory markers, and FOXP3 methylation status of blood T FR is comparable with tonsil-derived T FR . Moreover, we show that circulating T FR frequencies increase after influenza vaccination and correlate with anti-flu Ab responses, indicating a fully functional population. Multiple sclerosis (MS) was used as a model for autoimmune disease to investigate alterations in circulating T FR . MS patients had a significantly lower frequency of circulating T FR compared with healthy control subjects. Furthermore, the circulating T FR compartment of MS patients displayed an increased proportion of Th17-like T FR . Finally, T FR of MS patients had a strongly reduced suppressive function compared with healthy control subjects. We conclude that circulating T FR are a circulating memory population derived from lymphoid resident T FR , making them a valid alternative to investigate alterations in germinal center responses in the context of autoimmune diseases, and T FR impairment is prominent in MS. The Journal of Immunology, 2015, 195: 832-840. G iven the prompt emergence of somatically mutated B cells during B cell maturation in the germinal center (GC) response, it seems evident that regulatory pathways need to be engaged to secure the maintenance of self-tolerance (1, 2) . In this GC process, follicular Th cells (T FH ) are believed to select B cells based on their capacity to bind and present the specific Ag (3) . This survival-of-the-fittest mechanism requires a limited amount of T FH cells to ensure competition and thereby elimination of undesirable (autoreactive) B cells. The recently identified follicular regulatory T cells (T FR ) propose themselves as ideal candidates for regulating the normal GC response and preventing emergence of autoreactive B cells (4) (5) (6) . T FR cells comprise 5-25% of the GC T cells in mice and originate from Foxp3 + thymic-derived regulatory T cell (Treg) precursors (4) . Like T FH cells, T FR differentiation depends on CD28, B cell lymphoma 6 (BCL-6), signaling lymphocytic activation molecule-associated protein (SAP), and B cells (4) . Phenotypic analysis of T FR overlaps with the surface profile of T FH cells (CD4 + CXCR5 + PD-1 + ICOS + ), and both cell types also express BCL-6. In contrast with T FH , T FR do not express IL-20, IL-4, or CD40L. Besides sharing surface markers with T FH cells, T FR cells also express regulatory markers such as Foxp3, CD25, CTLA-4, glucocorticoid-induced TNFR-related protein, and IL-10 (4-6). The transcription factor NFAT2 has been identified as crucial for T FR development in mice, because it is essential for the induction of CXCR5 in these cells (7) . CXCR5 directs the migration of T FR into the GC where they suppress the magnitude of the GC response by regulating the number of T FH , B cells, and Abs. Taken together, T FR are a distinct population of Tregs located primarily in the GC, showing overlap with both Tregs and T FH.
Because regulation of (auto)antibody production primarily takes place in the GC, it is probable that an aberrant GC response can contribute to autoimmunity. In the absence of T FR , overwhelming outgrowth of nonspecific B cells leads to lower amounts of Agspecific B cells (8) . Furthermore, a lack of CXCR5 + Tregs in mice results in increased GC activity, including affinity maturation and differentiation toward plasma cells. In addition, PD-1 was found to be crucial for the homeostasis of T FR , because PD-1-deficient mice show increased numbers of T FR in lymph nodes. Also, the PD-1 pathway seems to impair T FR function, considering PD-1 deficiency results in an increased T FR suppressive capacity (9) . NFAT2-deficient T FR fail to control lupus-like disease manifestations in mice, supporting the proposition that T FR play a role in maintaining self-tolerance (7) .
In this study, we sought to identify the involvement of T FR in human disease by using multiple sclerosis (MS) as a model for an autoimmune disease (AID) with Treg disturbances (10) and elevated autoantibody levels (11, 12) . Peripheral blood (PB) is the most accessible source to analyze immune responses in healthy control subjects (HCs) and patients with AID. Therefore, we first determined whether blood T FR are a good representation to investigate T FR responses ongoing in secondary lymph nodes. To do so, a pairwise comparison was made between T FR derived from blood and tonsils of HCs. Next, circulating T FR were monitored after influenza vaccination to define GC-induced changes in this subset. Finally, circulating T FR alterations were investigated in MS patients and compared with HCs to evaluate their involvement in AID.
Materials and Methods

Human samples
Ethics approvals were obtained from each institute's human ethics committee. Tonsils and blood were obtained from adult patients without AIDs who were undergoing routine tonsillectomies at Hospital East-Limburg (Genk, Belgium; for detailed information, see Supplemental Table I ). Adult healthy volunteers were recruited for the vaccination of inactivated influenza vaccine Influvac S 2013/2014 (ABBOTT BIOLOGICALS B.V., Brussels, Belgium; for detailed information, see Supplemental Table I ). MS patients were recruited from the Rehabilitation and MS-Center (Overpelt, Belgium). Detailed clinical characteristics are listed in Supplemental Table I. PBMC purification and flow-cytometric analysis PB was collected in heparin-coated tubes (Venosafe plastic tubes; Terumo Europe N.V., Leuven, Belgium). Tonsils were cut into small pieces and singles cells were obtained using a cell strainer (EASYstrainer 70 mM; Greiner Bio-One BVBA/SPRL, Wemmel, Belgium). After collection of the plasma, density centrifugation was used to isolate the PBMCs (Lympholyte; Cedarlane Laboratories, SanBio B.V., Uden, the Netherlands). In line with recent publications, specific flow-cytometric markers were used to identify circulating T FR and T FH in human blood (13, 14) . For flowcytometric analysis of the T cell subsets, the following Abs were used: CD4 allophycocyanin, CD4 PE-CF594, CD4 FITC, CD45RO PE-CF594, CXCR5 Alexa Fluor 488, CXCR3 PE-CF594, CCR6-PerCP-Cy5.5, BCL-6 PE-CF594, Foxp3 PE-CF594 (all from BD Biosciences, Erembodegem, Belgium), CD25 PerCP-Cy5.5, CD127 PE, PD-1 PE-Cy7, CD45RA allophycocyanin-H7, CD31 allophycocyanin, CCR7 PE, CD62L allophycocyaninCy7, SAP-PE, Helios allophycocyanin (all from eBioscience, San Diego, CA); and CD25 allophycocyanin-Cy7 and CD27 allophycocyanin (from Biolegend, ImTec Diagnostics N.V., Antwerp, Belgium). B cell analysis was performed with CD19 PerCP-Cy5.5, IgD allophycocyanin-Cy7, and CD27 PE-Cy7 (all from BD Biosciences). Appropriate isotype controls were used to establish the proper gating strategies (all from BD Biosciences). All flow-cytometric analyzes were performed on a FACSAriaII flow cytometer and analyzed with FACSDiva software (BD Biosciences). For Foxp3 intranuclear staining, the eBioscience kit was used; for other intracellular stainings, the BD Cytofix/Cytoperm kit (BD) was used according to the manufacturers' guidelines.
Purification of CD4 T cell subsets
CD4
+ T cells were purified using CD4 negative selection (STEMCELL Technologies SARL, Grenoble, France). CD25 positive selection (STEMCELL Technologies SARL) was used to obtain a CD25 
CXCR5
+ PD-1 + T FH cells using FACSAria II (BD). Purity of the obtained cells was confirmed. Purified cells were pelleted and frozen at 280˚C. Next, the proportions of cells with a demethylated FOXP3 intron 1 allele were quantified by quantitative PCR on bisulfite-treated genomic DNA, as described previously (15) . 
Hemagglutination assay
Statistics
Statistical analyses were done using SAS 9.3, SAS Jump, and GraphPad Prism 6. Graphics were made using GraphPad Prism 6. Data sets were checked for normality, and for effect of age and sex. Analyses of the vaccination study was done using a mixed model (multiple measurements SAS 9.3). Analysis of multiple groups was done using ANOVA, nonparametric testing (Kruskal-Wallis), or linear correlations using SAS Jump. A Mann-Whitney U test was used for nonparametric unpaired data. Wilcoxon matched-pair test was used for nonparametric paired data. Tests were considered significant when p , 0.05 (two-sided tests).
Study approval
All human blood samples and tonsils were obtained with ethical approval of each institute's human ethics committee, the Medical Ethical Commission of University Hospital Leuven and Hospital East-Limburg, respectively. Written, informed consent was obtained from all study subjects.
Results
Human circulating T FR comprise a phenotypically distinct population
The presence and origin of genuine follicular subsets in the circulation remains controversial (2, 16) . This led us to question whether circulating T FR are phenotypically bona-fide T FR or rather represent a distinct population.
First, circulating T FR were phenotypically characterized in detail comparing blood and tonsils of HC (for detailed information, see Supplemental Table I ). Distinct subpopulations of Treg (CD4   +   CD25 + CD127 2 ) and conventional T cells (CD4 + CD25 2 CD127 + ) were found to express the follicular markers CXCR5 and PD-1 in blood and in tonsils (Fig. 1A) We next analyzed whether circulating follicular cells are phenotypically similar to those derived from tonsils using both follicular (ICOS, SAP, and BCL-6) and regulatory (Foxp3, Helios, and CD31) markers (Fig. 1C-E) . Circulating T FR and T FH did not express ICOS, whereas tonsil-derived cell subsets did. SAP, essential for T-B cell interaction, was significantly less expressed on circulating compared with tonsil-derived T FH , whereas no significant differences were found for T FR . A significantly higher proportion of T FR from tonsil express BCL-6 compared with circulating T FR , whereas T FH did not significantly differ in percentage of BCL-6 + cells. In contrast, the mean fluorescent intensity (MFI) of BCL-6 is significantly decreased on both blood T FR and T FH compared with their tonsil-derived counterparts. In addition, the expression levels of essential follicular markers (CXCR5, PD-1, BCL-6, and ICOS) are shown in Fig. 1D , again highlighting the phenotypical difference in follicular expression on blood T FH and T FR . The regulatory markers Foxp3 and Helios were equally expressed by T FR in tonsils and blood. No expression of regulatory markers was seen in T FH from any source. CD31 is a key molecule for the regulation of T cell homeostasis, effector function, and trafficking (17) (18) (19) . We found an increased expression of CD31 on the surface of circulating follicular cells, whereas the tonsil-derived counterparts did not express this marker. Taken together, these data show that human circulating T FR are not bonafide T FR because they lack high expression of CXCR5, PD-1, BCL-6, and ICOS, all essential follicular marker proteins.
Lastly, we determined the differentiation stage and effector phenotype of human circulating T FR . As a negative and positive control, we compared these cells with naive T cells and memory T cells, respectively, based on their CD45RO expression. Tonsilderived T FR and T FH cells have a CD45RO
+ and CD45RO 2 cell population unlike the circulating follicular cell subsets, which are all CD45RO + indicating a memory phenotype ( Fig. 2A) . To further characterize this memory phenotype, we used CCR7 and CD62L to distinguish effector memory T cells (T EM ) (Fig. 2B ) from central memory T cells (T CM ) (Fig. 2C) Fig. 2F ). An overview of the gating strategy of the flow-cytometric markers can be found in Supplemental Fig. 1 . Together, these data suggest that human circulating T FR are phenotypically distinct from their counterparts in the secondary lymphoid organs (tonsils were used as a model) because they 
Influenza vaccination boosts the number of circulating T FR
To investigate whether follicular cell activity is measurable in the blood, we next assessed the effect of vaccination on circulating follicular and B cell subsets. PB from HCs (n = 24; for detailed information, see Supplemental Table I ) was taken before (D0), and 1 d (D1), 1 wk (D7), and 3 wk (D21) after influenza vaccination. The percentage of circulating T FR cells significantly increased after 24 h (p , 0.001) and 7 d (p , 0.001) after vaccination, and returned back to baseline after 3 wk (Fig. 3A) . Memory T FR (CD45RO + CD45RA 2 T FR ) significantly increased (D1 and D7, p , 0.0001) after vaccination (Fig. 3B) , whereas the percentage of naive T FR (CD45RO 2 CD45RA + ) decreased significantly after 1 and 7 d (p = 0.01, data not shown). In line with other groups (21, 22) , we confirmed a significant increase in circulating T FH after vaccination (all time points, p , 0.001; Fig. 3C ). Similar to memory T FR , memory T FH increased significantly after influenza vaccination (D1 and D7: p , 0.001, D21: p , 0.05; Fig. 3D ). CXCR5 and PD-1 levels of circulating T FR and T FH decreased after vaccination (D1 and D7, p , 0.001) and returned to baseline after 3 wk (Fig. 3E-H) .
Next to circulating T cells, we also evaluated various B cells subtypes after vaccination. Similar to a previous report (21) , we show that percentage of plasmablasts (CD19 + CD27 + CD138 + ) increased after vaccination, although it did not reach statistical significance (D7, p = 0.07; Fig. 3I (Fig. 3J) .
To investigate whether the changes in the circulating T FR compartment are linked with the production of protective Ab responses, we performed HAI assays on plasma samples collected at baseline and D21 using two vaccine virus strains ( The percentage of both circulating T FR and plasmablast at D7 was correlated with the plasma titers for H1N1 strain and H3N2 strain after D21. Data are mean 6 SEM. Correlation analyses were done using a linear regression model. Analyses were done using a mixed model (multiple measurements SAS 9.3) with *p , 0.05, **p , 0.01, ***p , 0.001, ****p , 0.0001. the percentage of circulating T FR at D7 was positively correlated with postvaccination (D21) geometric mean titers (GMTs; p = 0.05 and p = 0.03; Fig. 3K, 3L) . Moreover, the percentage of plasmablasts significantly correlated with postvaccination H1N1pdm GMTs titers (p = 0.02; Fig. 3M ), but not with postvaccination H3N2 GMTs (Fig. 3N) .
In summary, we show that seasonal influenza vaccination in HCs leads to a significant increase in circulating (memory) T FR and T FH , which significantly correlate with titers of anti-vaccine Abs. We therefore conclude that circulating T FR are a relevant source to measure T FR activity and regulation of Ab responses in response to GC reactions.
Human circulating and tonsil-derived T FR are equally suppressive in vitro
To assess the functionality of circulating T FR , we made a pairwise comparison of the suppressive capacity of sorted blood-and tonsil-derived T FR and total Tregs of HCs (n = 7, Supplemental Table I ) using an in vitro coculture suppression assay. In brief, CFSE-labeled Tresp were cocultured in a 1:1 ratio with T FR , total Tregs, or no Tregs, and this in the absence or presence of CD3/ CD28 stimulation for 4 d (23) (24) (25) . Fig. 4A shows a representative example with the various conditions that were incorporated in the assay. Blood-derived T FR and Tregs were equally suppressive as their tonsil-derived counterparts, indicative of an equal functional activity (Fig. 4B) . In addition, the methylation status of the FOXP3 gene was assessed as previously described (15) . No significant difference in demethylated FOXP3 was found between T FR from blood compared with tonsils, indicating equal differentiation into Treg lineage (Fig. 4C) . Sorted total Tregs and T FH were used as a positive and negative control, respectively. Together, these results show that circulating T FR are equally suppressive and have the same level of demethylated FOXP3 as T FR of secondary lymphoid organs, governing them as a good alternative for functional analyses in the context of (auto)immunity.
Circulating T FR frequencies are decreased in patients with MS
Various groups, including ours, have reported an impairment in the Treg compartment of MS patients (10, 26-28) . Moreover, elevated levels of autoantibodies have been reported in MS (29, 30) . In light of these findings, we investigated whether the T FR com-partment known to regulate humoral immunity is disturbed in MS. We show a decreased frequency of circulating T FR in MS patients (n = 172; for more information, see Supplemental Table I ) compared with HCs (n = 107; for more information, see Supplemental Table I ; p , 0.0001; Fig. 5A ). Moreover, the T FH /T FR ratio was significantly increased in blood of MS patients (p , 0.0001; Fig.  5B ), indicating a relative imbalance between these interacting T cell populations. Age and sex had no effect on the frequency of circulating T FR in MS patients. We also looked into the effect of treatment but did not observe any effect (Supplemental Fig. 2A) . Moreover, in a 1-y follow-up study of patients treated with fingolimod, we did not detect an effect of treatment on percentage of blood T FR (Supplemental Fig. 2B ). In addition, no significant association could be found between T FR frequencies and Expanded Disability Status Scale, MS disease type, and disease duration ( Fig. 5C-E) .
Next, we assessed the T FR effector phenotypes in MS. T FR with a Th17-like phenotype are increased in MS patients (n = 14 for MS patients and n = 16 for HC, p = 0.0033; Fig. 5F ; for more information, see Supplemental Table I ), whereas other effector phenotypes did not differ. In contrast with T FR , no alterations were found in the T FH compartment of MS (Supplemental Fig. 3) .
Taken together, our results show that the frequency of circulating T FR is significantly decreased in patients with MS, and that the Th17 effector subpopulation of MS-derived T FR is increased.
Circulating T FR are functionally impaired in patients with MS
The functionality of MS-derived circulating T FR was tested using the in vitro coculture suppression assay described earlier (Fig. 6A) . MS-derived T FR displayed a strongly impaired suppression compared with HCs (HC: n = 15, MS: n = 12, p # 0.0001; for more information, see Supplemental Table I ; Fig. 6B ). We further confirmed that conventional Tregs from these MS patients were also significantly impaired (p , 0.0001; Fig. 6B ). When correlating the suppressive function of both Tregs and T FR from the same donor, a significant positive association was found for both MS patients and HCs (Fig. 6C) . For one MS patient (relapsing-remitting MS, no treatment), the suppressive function was assessed at two time points 1 mo apart. The suppressive capacity of Tregs and T FR (at a 1:1 ratio) at both time points was in the same range (data not shown), confirming the reproducibility and stability of the assay, as well as the constant nature of Treg/ T FR function.
In conclusion, we found that both Tregs and T FR isolated from MS patients had a reduced capacity to suppress the proliferation of Tresp showing a functional impairment of circulating T FR in MS patients. 
Discussion
In this study, we provide an insight into the phenotype and function of circulating T FR in humans. Although circulating T FR represent a population that is phenotypically distinct from their tonsilderived counterparts, they are an eligible source to measure GC responses ongoing in secondary lymphoid organs. We showed a decreased frequency and impaired functionality of circulating T FR in MS patients, indicating their involvement in breakdown of self-tolerance in human AIDs. These conclusions led us to two main questions: What is the origin and fate of these cells? And what explains the impairment of the circulating T FR population in MS? Circulating T FR are not considered bona-fide T FR because they lack high expression of essential follicular markers, such as BCL-6 and ICOS. These results are consistent with findings in circulating T FH and likely indicate that follicular markers upregulate only after homing to the GC (16). This notion is further supported by the decreased expression of CXCR5 and PD-1 on circulating T FR after influenza vaccination, which could reflect homing of CXCR5 hi PD-1 hi T FR to the GC. In mice, T FR were shown to originate from thymic-derived Tregs (4) . In line with these findings, we showed that human blood T FR express Helios and demethylated FOXP3 to a similar extent as tonsil-derived T FR and are fully functional. Furthermore, we characterized these cells as central memory with a higher expression of both CCR7 and CD62L compared with tonsil-derived T FR , allowing recirculation to the lymph nodes. He at al. (16) showed that circulating T FH also have a higher expression of these markers. In addition, we found a significant increase in the percentage of memory T FR after seasonal influenza vaccination. It is therefore possible that they originate from GC T FR , migrate to the circulation after a GC response, and become a central effector memory population that is long-lived and has the capacity to recirculate. Another theory proposed by He at al. (16) suggested that circulating T FH cells are a population of cells that leave the GC response in its early phase, before developing in mature T FH cells, governing a "precursor memory" population. We showed that although the expression of Foxp3 and Helios was the same in T FR , blood-derived follicular cells are CD31 + whereas the tonsil-derived follicular cells are negative. It has been reported that CD31 expression regulates T cell activation and can thus prevent hyperactivation (17, 19) . In addition, recent evidence showed that the loss of CD31 after activation leads to a stable interaction of T cells with B cells (18) . This could indicate that circulating T FR are indeed a central memory population that is quiescent by nature and will lose CD31 expression upon activation. In line with this, a recent mouse study (31) reported that circulating T FR are a long-lived memory population that homes to GC after reactivation. A human study showed that follicular T cell populations do not need an ongoing GC response for their maintenance because treatment with rituximab, known to eliminate GC B cells, had no effect on the follicular T cell compartment (32) . Together all these data indicate that circulating T FR are a distinct effector memory population that persists for a long time and is able to recirculate to the lymph nodes when needed.
MS, an AID of the CNS, was used as a model to investigate the role of circulating T FR in autoimmunity. A functional impairment of Tregs in MS was shown by various groups (26-28, 33, 34 ). We 
CD127
+ confirmed an impairment of Tregs in MS patients and found that T FR from the same patients are also defective in their capacity to suppress Tresp. Also, a decreased percentage of blood T FR in MS patients was found compared with HCs. Based on the chemokine markers suggested by Morita et al. (20) , we show that the amount of Th17-like T FR is increased in MS patients. A more proinflammatory phenotype could explain the decreased suppressive function of circulating T FR . Furthermore, this impairment could originate from a defect in CTLA-4 signaling because CTLA-4 is essential in T FR function (35) . An alternative explanation for the reduced frequency and suppressive activity in the circulating T FR compartment could be that the most potent T FR homed to the lymph nodes to suppress the ongoing GC response. Sage et al. (31) showed that circulating T FR in mice require dendritic cells for their development and cytokine production. Circulating dendritic cells in MS were shown to have a decreased regulatory character and could in this way contribute to an impairment of functional circulating T FR (36) .
In conclusion, we believe that follicular populations in the blood form a source of responsive memory cells that quickly reacts when encountering an Ag again. Impairment of circulating T FR and T FH could contribute to the pathogenesis of various AIDs, including MS, highlighting their importance in conserving normal immunity. 
